AuraVax Therapeutics Secures Grant for Groundbreaking Viral Challenge Study AuraVax Therapeutics has received funding from the Gates Foundation to explore NanoSTING-001 effectiveness against swine influenza, paving the way for novel respiratory therapies.

AuraVax Therapeutics Secures Grant for Groundbreaking Viral Challenge Study #United_States #Gates_Foundation #Houston #AuraVax #NanoSTING-001